As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to European Commission in 2018 about European Commission consultation: Good Clinical Practice (GCP) for advanced therapy medicinal products (ATMPs) can be found below.